DCTD Programs
FOLLOW DCTDLast Updated: 10/22/2018
DCTD’s Translational Research Program Announces Fiscal Year 2018 SPORE Grantees
The Translational Research Program (TRP) announced its successfully competed FY2018 Specialized Programs of Research Excellence (SPORE) grantees. The SPORE program uses the P50 and U54 grant funding mechanisms to promote collaborative, interdisciplinary, translational cancer multi-project research. SPOREs are primarily focused on organ site disease, but also on themes that cut across organ sites. Including the 2018 grantees, there are now 54 SPOREs located at academic centers in 22 states.
FY 2018 SPORE Grantees
| Principal Investigator | Institution | Type of Cancer |
|---|---|---|
| *Mitchel Berger, MD | University of California, San Francisco | Brain |
| Dean Bajorin, MD and David Solit, MD | Memorial Sloan Kettering Cancer Center | Prostate |
| *Mark Bosenberg, MD, PhD and Harriet Kluger, MD | Yale University | Skin |
| *Stephen Forman, MD and Larry Kwak, MD, PhD | City of Hope | Lymphoma |
| *Hagop Kantarjian, MD and Jean-Pierre Issa, MD | University of Texas MD Anderson | Leukemia |
| Maciej Lesniak, MD | Northwestern University | Brain |
| *Dan Link, MD | Washington University, St. Louis | Leukemia |
| Mark McNiven, PhD and Lewis Roberts, MB, ChB, PhD | Mayo Clinic | Hepatobiliary |
| *Peter Nelson, MD | Fred Hutchinson | Prostate |
| *Charles Perou, PhD and Shelley Earp, MD | University of North Carolina, Chapel Hill | Breast |
| le-Ming Shih, MD, PhD | Johns Hopkins University | Ovarian |
*Grant Renewal
The goals of the SPORE program include:
- Translating novel scientific discoveries from the laboratory and/or population studies to the clinic for testing in humans with cancer or at risk for cancer
- Determining the biological basis for clinical observations
- Using specimens from clinical studies to determine correlations between biomarkers and outcomes in patients
- Promoting collaborations between SPOREs, Cancer Centers, other NCI/NIH funded mechanisms and programs, and outside organizations
- Promoting pilot projects and career enhancement of researchers new to translational research
- Supporting research in high incidence and rare cancers
- Encouraging communication with advocates and advocate organizations to obtain advice from the patient perspective
Contact TRP staff for more information on the SPORE program.